NAFLD accelerates arterial perfusion in rabbit VX2 liver tumors: a sonoVue-based contrast-enhanced ultrasound study

非酒精性脂肪性肝病加速兔VX2肝肿瘤的动脉灌注:一项基于SonoVue对比增强超声的研究

阅读:1

Abstract

OBJECTIVE: To investigate whether the background of non-alcoholic fatty liver disease(NAFLD) affects the microcirculation characteristics of VX2 hepatomas, analyze the influence of the fatty liver background on tumor angiogenesis and proliferative activity. METHODS: 24 rabbits were used to establish VX2 tumor models in the background of normal liver and NAFLD. Contrast-enhanced ultrasound was performed using SonoVue. The time-intensity curve(TIC) parameters were extracted and the expression levels of microvessel density(MVD), vascular endothelial growth factor(VEGF), Ki-67 and PCNA in tumor tissues were detected and analyzed. RESULT: The TIC parameter arrival time(AT) and rise time(RT) of VX2 liver tumors decreased under the background of NAFLD(P<0.05). There was no statistically significant difference in the tumor size, MVD, VEGF, Ki-67 and PCNA expression levels between the NAFLD group and the normal liver group(P>0.05). PI was positively correlated with MVD in both normal liver(r=0.51, P<0.05) and NAFLD(r=0.67, P<0.05) backgrounds. CONCLUSION: The background of NAFLD leads to an increase in the arterial flow velocity of VX2 tumors in the liver, but it has not significantly affected the level of angiogenesis and proliferation. The CEUS parameters can effectively reflect the level of tumor microangiogenesis and are effective tools for evaluating microvessels.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。